select a format

Single User License
USD 2000 INR 129380
Site License
USD 4000 INR 258760
Corporate User License
USD 6000 INR 388140

Alternatively

Request a quote
Request a Customized research
Request for Sample Report

NEWSLETTER BY CATEGORY




Recent Viewed Reports


Why Ken Reasearch?


Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"


Post-Operative Pain-Pipeline Review, H2 2015

Post-Operative Pain-Pipeline Review, H2 2015


  • Products Id :- GMDHC7286IDB
  • |
  • Pages: 169
  • |
  • October 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Post-Operative Pain-Pipeline Review, H2 2015

Summary

Global Markets Direct's, 'Post-Operative Pain-Pipeline Review, H2 2015', provides an overview of the Post-Operative Pain's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Post-Operative Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post-Operative Pain and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global therapeutic landscape of Post-Operative Pain

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Post-Operative Pain and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Post-Operative Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Post-Operative Pain pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Post-Operative Pain

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Post-Operative Pain pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 7

Global Markets Direct Report Coverage 7

Post-Operative Pain Overview 8

Therapeutics Development 9

Pipeline Products for Post-Operative Pain-Overview 9

Pipeline Products for Post-Operative Pain-Comparative Analysis 10

Post-Operative Pain-Therapeutics under Development by Companies 11

Post-Operative Pain-Pipeline Products Glance 13

Late Stage Products 13

Clinical Stage Products 14

Early Stage Products 15

Unknown Stage Products 16

Post-Operative Pain-Products under Development by Companies 17

Post-Operative Pain-Companies Involved in Therapeutics Development 20

A. Menarini Industrie Farmaceutiche Riunite Srl 20

AcelRx Pharmaceuticals, Inc. 21

Adynxx, Inc. 22

Amorsa Therapeutics Inc. 23

AngioChem Inc. 24

AskAt Inc. 25

Boehringer Ingelheim GmbH 26

Cara Therapeutics, Inc. 27

Chong Kun Dang Pharmaceutical Corp. 28

Colby Pharmaceutical Company 29

Cytogel Pharma, LLC 30

DURECT Corporation 31

Echo Pharmaceuticals B.V. 32

Flexion Therapeutics, Inc. 33

Fujimoto Pharmaceutical Corporation 34

Galleon Pharmaceuticals 35

Grunenthal GmbH 36

GW Pharmaceuticals Plc 37

Heron Therapeutics, Inc. 38

Immupharma Plc 39

Laboratorios Del Dr. Esteve S.A. 40

Lipocure Ltd. 41

Medtronic plc 42

Navigen Pharmaceuticals, Inc. 43

Orbis Biosciences, Inc. 44

Orion Oyj 45

PainReform Ltd. 46

Pharmazz, Inc. 47

PhytoHealth Corporation 48

Recro Pharma, Inc. 49

Takeda Pharmaceutical Company Limited 50

Thar Pharmaceuticals, Inc. 51

Trevena, Inc. 52

Post-Operative Pain-Therapeutics Assessment 53

Assessment by Monotherapy Products 53

Assessment by Combination Products 54

Assessment by Target 55

Assessment by Mechanism of Action 58

Assessment by Route of Administration 61

Assessment by Molecule Type 63

Drug Profiles 65

(bupivacaine hydrochloride + meloxicam)-Drug Profile 65

(dexketoprofen + tramadol hydrochloride)-Drug Profile 66

AM-4-Drug Profile 67

AMS-410 ER12-Drug Profile 68

ANG-2002-Drug Profile 69

ARX-04-Drug Profile 70

AYX-1-Drug Profile 72

BI-1026706-Drug Profile 73

bupivacaine hydrochloride-Drug Profile 74

bupivacaine hydrochloride-Drug Profile 75

bupivacaine hydrochloride SR-Drug Profile 77

CKD-943-Drug Profile 79

CMX-020-Drug Profile 80

CPC-123-Drug Profile 81

CR-845-Drug Profile 82

Cyt-1010-Drug Profile 85

dexmedetomidine hydrochloride-Drug Profile 87

dronabinol-Drug Profile 89

E-52862-Drug Profile 91

ECP-1014-Drug Profile 93

fadolmidine hydrochloride-Drug Profile 94

FX-007-Drug Profile 96

GAL-044-Drug Profile 97

grapiprant-Drug Profile 98

IPP-102199-Drug Profile 100

ketamine hydrochloride-Drug Profile 101

ketamine hydrochloride ER-Drug Profile 103

MDT-10013-Drug Profile 104

meloxicam-Drug Profile 105

nabiximols-Drug Profile 106

nalbuphine hydrochloride-Drug Profile 109

oliceridine-Drug Profile 110

Peptide for Post Operative Pain-Drug Profile 111

PMZ-2010-Drug Profile 112

RBM-004-Drug Profile 114

ropivacaine-Drug Profile 115

ropivacaine ER-Drug Profile 116

sufentanil citrate-Drug Profile 117

T-109-Drug Profile 120

tapentadol hydrochloride-Drug Profile 121

tramadol hydrochloride-Drug Profile 123

tramadol hydrochloride-Drug Profile 124

URB-937-Drug Profile 125

VVZ-149-Drug Profile 126

Post-Operative Pain-Recent Pipeline Updates 127

Post-Operative Pain-Dormant Projects 155

Post-Operative Pain-Discontinued Products 157

Post-Operative Pain-Product Development Milestones 158

Featured News & Press Releases 158

Appendix 165

Methodology 165

Coverage 165

Secondary Research 165

Primary Research 165

Expert Panel Validation 165

Contact Us 165

Disclaimer 166

List of Tables

Number of Products under Development for Post-Operative Pain, H2 2015 12

Number of Products under Development for Post-Operative Pain-Comparative Analysis, H2 2015 13

Number of Products under Development by Companies, H2 2015 14

Comparative Analysis by Late Stage Development, H2 2015 16

Comparative Analysis by Clinical Stage Development, H2 2015 17

Comparative Analysis by Early Stage Development, H2 2015 18

Comparative Analysis by Unknown Stage Development, H2 2015 19

Products under Development by Companies, H2 2015 20

Products under Development by Companies, H2 2015 (Contd..1) 21

Products under Development by Companies, H2 2015 (Contd..2) 22

Post-Operative Pain-Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H2 2015 23

Post-Operative Pain-Pipeline by AcelRx Pharmaceuticals, Inc., H2 2015 24

Post-Operative Pain-Pipeline by Adynxx, Inc., H2 2015 25

Post-Operative Pain-Pipeline by Amorsa Therapeutics Inc., H2 2015 26

Post-Operative Pain-Pipeline by AngioChem Inc., H2 2015 27

Post-Operative Pain-Pipeline by AskAt Inc., H2 2015 28

Post-Operative Pain-Pipeline by Boehringer Ingelheim GmbH, H2 2015 29

Post-Operative Pain-Pipeline by Cara Therapeutics, Inc., H2 2015 30

Post-Operative Pain-Pipeline by Chong Kun Dang Pharmaceutical Corp., H2 2015 31

Post-Operative Pain-Pipeline by Colby Pharmaceutical Company, H2 2015 32

Post-Operative Pain-Pipeline by Cytogel Pharma, LLC, H2 2015 33

Post-Operative Pain-Pipeline by DURECT Corporation, H2 2015 34

Post-Operative Pain-Pipeline by Echo Pharmaceuticals B.V., H2 2015 35

Post-Operative Pain-Pipeline by Flexion Therapeutics, Inc., H2 2015 36

Post-Operative Pain-Pipeline by Fujimoto Pharmaceutical Corporation, H2 2015 37

Post-Operative Pain-Pipeline by Galleon Pharmaceuticals, H2 2015 38

Post-Operative Pain-Pipeline by Grunenthal GmbH, H2 2015 39

Post-Operative Pain-Pipeline by GW Pharmaceuticals Plc, H2 2015 40

Post-Operative Pain-Pipeline by Heron Therapeutics, Inc., H2 2015 41

Post-Operative Pain-Pipeline by Immupharma Plc, H2 2015 42

Post-Operative Pain-Pipeline by Laboratorios Del Dr. Esteve S.A., H2 2015 43

Post-Operative Pain-Pipeline by Lipocure Ltd., H2 2015 44

Post-Operative Pain-Pipeline by Medtronic plc, H2 2015 45

Post-Operative Pain-Pipeline by Navigen Pharmaceuticals, Inc., H2 2015 46

Post-Operative Pain-Pipeline by Orbis Biosciences, Inc., H2 2015 47

Post-Operative Pain-Pipeline by Orion Oyj, H2 2015 48

Post-Operative Pain-Pipeline by PainReform Ltd., H2 2015 49

Post-Operative Pain-Pipeline by Pharmazz, Inc., H2 2015 50

Post-Operative Pain-Pipeline by PhytoHealth Corporation, H2 2015 51

Post-Operative Pain-Pipeline by Recro Pharma, Inc., H2 2015 52

Post-Operative Pain-Pipeline by Takeda Pharmaceutical Company Limited, H2 2015 53

Post-Operative Pain-Pipeline by Thar Pharmaceuticals, Inc., H2 2015 54

Post-Operative Pain-Pipeline by Trevena, Inc., H2 2015 55

Assessment by Monotherapy Products, H2 2015 56

Assessment by Combination Products, H2 2015 57

Number of Products by Stage and Target, H2 2015 59

Number of Products by Stage and Mechanism of Action, H2 2015 62

Number of Products by Stage and Route of Administration, H2 2015 65

Number of Products by Stage and Molecule Type, H2 2015 67

Post-Operative Pain Therapeutics-Recent Pipeline Updates, H2 2015 130

Post-Operative Pain-Dormant Projects, H2 2015 158

Post-Operative Pain-Dormant Projects (Contd..1), H2 2015 159

Post-Operative Pain-Discontinued Products, H2 2015 160

List of Figures

Number of Products under Development for Post-Operative Pain, H2 2015 12

Number of Products under Development by Companies, H2 2015 14

Comparative Analysis by Late Stage Development, H2 2015 16

Comparative Analysis by Clinical Stage Development, H2 2015 17

Comparative Analysis by Early Stage Products, H2 2015 18

Assessment by Monotherapy Products, H2 2015 56

Assessment by Combination Products, H2 2015 57

Number of Products by Top 10 Targets, H2 2015 58

Number of Products by Stage and Top 10 Targets, H2 2015 58

Number of Products by Top 10 Mechanism of Actions, H2 2015 61

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 61

Number of Products by Top 10 Routes of Administration, H2 2015 64

Number of Products by Stage and Top 10 Routes of Administration, H2 2015 64

Number of Products by Molecule Types, H2 2015 66

Number of Products by Stage and Molecule Types, H2 2015 66

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

A. Menarini Industrie Farmaceutiche Riunite Srl

AcelRx Pharmaceuticals, Inc.

Adynxx, Inc.

Amorsa Therapeutics Inc.

AngioChem Inc.

AskAt Inc.

Boehringer Ingelheim GmbH

Cara Therapeutics, Inc.

Chong Kun Dang Pharmaceutical Corp.

Colby Pharmaceutical Company

Cytogel Pharma, LLC

DURECT Corporation

Echo Pharmaceuticals B.V.

Flexion Therapeutics, Inc.

Fujimoto Pharmaceutical Corporation

Galleon Pharmaceuticals

Grunenthal GmbH

GW Pharmaceuticals Plc

Heron Therapeutics, Inc.

Immupharma Plc

Laboratorios Del Dr. Esteve S.A.

Lipocure Ltd.

Medtronic plc

Navigen Pharmaceuticals, Inc.

Orbis Biosciences, Inc.

Orion Oyj

PainReform Ltd.

Pharmazz, Inc.

PhytoHealth Corporation

Recro Pharma, Inc.

Takeda Pharmaceutical Company Limited

Thar Pharmaceuticals, Inc.

Trevena, Inc.

st-Operative Pain-Therapeutics Assessment

Post-Operative Pain Therapeutic Products under Development, Key Players in Post-Operative Pain Therapeutics, Post-Operative Pain Pipeline Overview, Post-Operative Pain Pipeline, Post-Operative Pain Pipeline Assessment


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com